Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients

Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients - Evaluation of Galectin-3 expression as a prognostic factor in non-small cell lung cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026869

Enrollment

250

Registered

2017-04-05

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non-small cell lung cancer patients who underwent surgical resection in Shiga University of Medical Science Hospital between January 2007 and December 2015.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

Measure	Time frame
Recurrence-free survival (RFS)	—

Secondary

Measure	Time frame
1) Overall survival (OS) 2) To evaluate the correlation between Galectin-3 expression in non-small cell lung cancer tissues and clinicopathological features 3) To investigate the correlation between Galectin-3 expression in tissue and serum from non-small cell lung cancer patients	—

Countries

Japan

Contacts

Public ContactYoko Kataoka

Shiga University of Medical Science Department of Surgery

hqsurg2@belle.shiga-med.ac.jp077-548-2244

Outcome results